| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.5M | $1.3M | $142.0K |
| YoY Revenue Growth % | +14.4% | +815.5% | — |
| Gross Profit | $552.0K | $450.0K | — |
| Gross Margin % | 37.1% | 34.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.7M | -$9.0M | -$11.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$11.1M | -$30.7M | -$11.1M |
| EBITDA (Normalized) | -$11.6M | -$9.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$9.1M | -$9.7M | -$10.5M |
| Capital Expenditures (CapEx) | $125.0K | $30.0K | — |
| Free Cash Flow (FCF) | -$9.2M | -$9.7M | -$10.5M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $20.0M | $17.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $20.3M | $17.7M | — |